(Q50450269)

English

Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.

scientific article published on 14 August 2008

Statements

Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit